Director of Future Technology Platforms at US NGO think tank the Special Competitive Studies Project Abigail Kukura sat for an exclusive interview with The Yuan’s Andrii Buvailo - pharma analyst and BiopharmaTrend.com co-founder - and read her auguries for US biotech’s hereafter.

Clinical trials are key in testing new treatments and their suitability for widespread use. AI is already making drug discovery cheaper and more efficient, and is now boosting clinical trials’ success. Pharma analyst and BiopharmaTrend.com co-founder Andrii Buvailo reports.

When it comes to the identification, testing, and clinical trials of new drug candidates, AI has an important role to play not only by making this process more efficient and cost-effective, but also able to produce entirely new innovations and discoveries that would not otherwise be possible. How close are we to realizing a sci-fi future where super-drugs are discovered, invented, tested, replicated, and brought to market entirely by AI?